Citadel Advisors’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.6M Buy
2,511,015
+2,063,207
+461% +$4.86M ﹤0.01% 3893
2025
Q4
$855K Sell
447,808
-33,641
-7% -$79.7K ﹤0.01% 7751
2025
Q3
$1.07M Buy
+481,449
New +$1.16M ﹤0.01% 7398
2025
Q1
Sell
-28,616
Closed -$103K 14553
2024
Q4
$103K Sell
28,616
-5,481
-16% -$27.3K ﹤0.01% 11442
2024
Q3
$194K Sell
34,097
-339,560
-91% -$2.04M ﹤0.01% 10193
2024
Q2
$1.73M Buy
373,657
+39,139
+12% +$233K ﹤0.01% 5589
2024
Q1
$2.73M Buy
334,518
+287,304
+609% +$2.23M ﹤0.01% 4947
2023
Q4
$267K Sell
47,214
-346,728
-88% -$791K ﹤0.01% 9392
2023
Q3
$733K Sell
393,942
-275,540
-41% -$840K ﹤0.01% 7247
2023
Q2
$1.84M Buy
669,482
+142,328
+27% +$457K ﹤0.01% 5291
2023
Q1
$1.66M Buy
527,154
+147,654
+39% +$869K ﹤0.01% 5730
2022
Q4
$2.24M Buy
379,500
+249,713
+192% +$2.07M ﹤0.01% 5265
2022
Q3
$1.14M Buy
129,787
+101,836
+364% +$1.06M ﹤0.01% 6713
2022
Q2
$211K Sell
27,951
-80,278
-74% -$706K ﹤0.01% 10589
2022
Q1
$2.63M Sell
108,229
-53,727
-33% -$1.3M ﹤0.01% 5477
2021
Q4
$5.21M Buy
161,956
+121,621
+302% +$4.81M ﹤0.01% 4216
2021
Q3
$1.8M Sell
40,335
-70,443
-64% -$3.02M ﹤0.01% 6638
2021
Q2
$4.19M Buy
110,778
+90,527
+447% +$3.24M ﹤0.01% 4824
2021
Q1
$749K Sell
20,251
-83,622
-81% -$3.33M ﹤0.01% 8796
2020
Q4
$3.44M Buy
+103,873
New +$3.01M ﹤0.01% 4349

Other funds holding CCCC